7400 Fannin St., Suite 1180
Houston, Texas 77054
Phone (713) 790-9900
Fax (713) 790-9901

Robert B. McWilliams, MD
Reproductive Endocrinology
and Gynecology

 


OUR STAFF

INFERTILITY
MALE

INFERTILITY

PATIENT INFORMATION

EDUCATIONAL
ARTICLES

FERTILITY TESTING

FERTILITY MEDICATIONS


"ART" THERAPIES

DONOR EGG


IUI

FEMALE
HEALTH
ISSUES

LOCATIONS

CONTACT US

HOME

 

SEARCH OUR
SITE


Alternatives to Hysterectomy

I. Facts

a. Hysterectomy is 2nd most commonly performed major operation in United States, 600,000 per year.

b.Approximately one in three women will have this operation during their lifetime, usually before the age of 60.

c. Most common indications:

i.Fibroid uterus
ii.Abnormal uterine bleeding (heavy menstrual flow) iii.Endometriosis/chronic pelvic pain iv.Pelvic organ prolapse

d. Morbidity associated with hysterectomy; Death = 0.1-0.2%

i. Increase with age of patient
ii. Increase with medical complications

iii. Increase with difficulty of procedure

iv. Increase with association with pregnancy

e. Causes of death

i. Blood clot to lungs
ii. Cardiac arrest size
iii. hemorrhage
iv. Infection

v. Injury to adjacent organs

1. Bladder
2. Bowel
3. Uterus

II. Alternatives

a. Alternatives to hysterectomy can provide excellent treatment outcomes for many women. In general, these alternatives are underutilized. For some women, alternative treatments fail and hysterectomy provides the best approach.

b. For women who require hysterectomy, the laparoscopic approach affords the benefit of less postoperative discomfort, shorter hospital stay, and quicker recovery.

c.Morbidity associated with alternative approaches depend on:

i. Type of approach

ii. Nature of illness

iii. Physical, medical condition of patient
iv. Experience of physician v.
v. Patient's perspective and future desires

III. Fibroids

a. Definitive therapy = total abdominal hysterectomy
b. Expectant management

iii. Less radical surgical therapy

1. Endoscopic removal
2. Myolysis
3. Myomectomy
4. Uterine arterial embolization
5. Hormonal therapy
6. GnRHa therapy iv. Recurrence rates = 10-30%

IV. Subsequent hysterectomy = 20-25%

e. Heavy menstrual flow (menorrhagia)

i. 15-20% of healthy women experience debilitating menorrhagia

ii. Past therapy recommended = vaginal hysterectomy

iii. Alternatives today an option as nearly 50% of uterine specimens obtained at hysterectomy for menorrhagia are disease free on pathologic examination

iv. Less radical surgical therapy

1. Medical therapy

a. NSAIDs

b. Progestins

c. Oral contraceptives

d. GnRHa

2. Surgical therapy

a. D & C

b. Endometrial ablation

i. Recurrence rate = 25-30%

ii. Reoperation rate = 10-20%

iii. Subsequent hysterectomy = 20%

iv. Contraindications

1. pelvic malignancy

2. future fertility

3. acute pelvic infection

4. large fibroids

5. large uterus

c. Hysteroscopic resection of polyps/fibroids

f. Endometriosis/chronic pelvic pain

i. Abdominal inspection for assessment of extent of disease

ii. Definitive therapy = Total abdominal hysterectomy with bilateral salpino-oophorectomy, appendectomy, excision of remaining adhesions or implants of endometriosis

iii. Conservative approach

1. Medical therapy

2. Laparoscopic surgery

3. Presacral neurectomy

g. Pelvic organ prolapse

i. Operative approaches

1. abdominal hysterectomy with bladder suspension

2. vaginal hysterectomy with sling procedure

3. vaginal repair

ii. Nonoperative approaches

1. pessaries

2. exercises

3. estrogens in menopausal women

Robert B. McWilliams, M.D.

Return to Infertility and Women's Health Care Articles